Technical Analysis for PLXP - PLx Pharma Inc.

Grade Last Price % Change Price Change
B 10.61 -1.12% -0.12
PLXP closed down 1.12 percent on Friday, April 16, 2021, on 43 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical PLXP trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish -1.12%
Jack-in-the-Box Bullish Bullish Swing Setup -1.12%
Pocket Pivot Bullish Swing Setup -1.12%
Narrow Range Bar Range Contraction -1.12%
NR7 Range Contraction -1.12%
Older End-of-Day Signals for PLXP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


PLx Pharma Inc. Description

PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325 mg, PL1100/PL1200 Ibuprofen. PLxGuard delivery system uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs to selectively release these drugs to targeted portions of the GI tract. The Company’s lead product Aspertec 325 mg is a liquid-fill aspirin capsule for prevention of cardiovascular disease. Through PLxGuard delivery system the Company creates a lipid-based formulation of ibuprofen, PL1200 Ibuprofen Capsules, 200 mg.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Acid Drugs Organic Compounds Cardiovascular Disease Lipid Acids Analgesics Fatty Acid Stage Specialty Pharmaceutical Hepatotoxins Fatty Acids Lipids Carboxylic Acids Ibuprofen Aspirin

Is PLXP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 10.9699
52 Week Low 2.31
Average Volume 384,527
200-Day Moving Average 5.25
50-Day Moving Average 8.54
20-Day Moving Average 9.35
10-Day Moving Average 9.78
Average True Range 0.68
ADX 33.21
+DI 32.50
-DI 12.35
Chandelier Exit (Long, 3 ATRs ) 8.92
Chandelier Exit (Short, 3 ATRs ) 10.20
Upper Bollinger Band 10.79
Lower Bollinger Band 7.92
Percent B (%b) 0.94
BandWidth 30.68
MACD Line 0.57
MACD Signal Line 0.45
MACD Histogram 0.1263
Fundamentals Value
Market Cap 97.15 Million
Num Shares 9.16 Million
EPS -3.87
Price-to-Earnings (P/E) Ratio -2.74
Price-to-Sales 1005.96
Price-to-Book 0.00
PEG Ratio -0.11
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.33
Resistance 3 (R3) 11.36 11.16 11.21
Resistance 2 (R2) 11.16 10.97 11.14 11.17
Resistance 1 (R1) 10.88 10.86 10.78 10.85 11.13
Pivot Point 10.68 10.68 10.63 10.66 10.68
Support 1 (S1) 10.40 10.49 10.30 10.37 10.09
Support 2 (S2) 10.20 10.38 10.18 10.05
Support 3 (S3) 9.92 10.20 10.01
Support 4 (S4) 9.89